216 studies found for:    hepatitis c phase 2 | Open Studies
Show Display Options
Rank Status Study
1 Unknown  CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects
Condition: Chronic Hepatitis C
Interventions: Drug: ChronVac-C + SOC;   Drug: SOC
2 Recruiting A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Condition: Hepatitis C, Chronic
Interventions: Drug: Simprenavir;   Drug: Daclatasvir;   Drug: Ribavarin
3 Not yet recruiting A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV
Condition: Chronic Hepatitis C
Interventions: Drug: Victrelis® (boceprevir) 800mg by mouth, TID (200 mg tablets);   Drug: Peg-Intron® (peginterferon-α-2b), 1.5ug/kg sc injection;   Drug: Rebetol® (ribavirin), 1000/1200mg by mouth daily
4 Not yet recruiting An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant
Condition: Hepatitits C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir;   Drug: Ribavirin
5 Recruiting Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Miravirsen;   Drug: Telaprevir;   Drug: Ribavirin
6 Recruiting A Study to Evaluate Chronic Hepatitis C Infection in Adult Liver Transplant Recipients
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: ribavirin (RBV)
7 Recruiting Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
Condition: Hepatitis C, Liver Disease
Interventions: Drug: DEB025 200mg;   Drug: DEB025 300mg;   Drug: DEB025 400mg
8 Recruiting Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C
Condition: Hepatitis C Infection
Interventions: Biological: MBL-HCV1;   Drug: Telaprevir (Part 1);   Drug: Sofosbuvir (Part 2)
9 Recruiting Pharmacokinetics, Pharmacodynamics and Safety of DEB025/Alisporivir in Combination With Ribavirin Therapy in Chronic Hepatitis C Genotype 2 and 3 Patients Who Have Previously Failed Interferon Therapy or Are Intolerant or Unable to Take Interferon
Condition: Hepatitis C, Liver Disease
Intervention: Drug: DEB025 and RBV
10 Unknown  A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Celgosivir;   Drug: Peginterferon alfa 2b + ribavirin
11 Recruiting Study of Efficacy and Safety of MK-5172 + MK-8742 in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)
Condition: Chronic Hepatitis C
Interventions: Drug: MK-5172;   Drug: MK-8742
12 Unknown  Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance
Condition: Hepatitis C
Intervention: Drug: thalidomide
13 Recruiting Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders
Condition: Chronic HCV Infection
Interventions: Drug: LDV/SOF;   Drug: Sofosbuvir;   Drug: Ribavirin
14 Recruiting Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF;   Drug: RBV
15 Recruiting Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Subjects With Chronic Genotype 1, 2, 3, or 6 HCV Infection
Condition: Chronic Hepatitis C
Interventions: Drug: LDV/SOF FDC;   Drug: SOF;   Drug: RBV;   Drug: PEG;   Drug: GS-9669;   Drug: GS-5816
16 Recruiting THISTLE - The HIV-HCV Silibinin Trial
Conditions: HIV;   Hepatitis C
Intervention: Drug: Intravenous Silibinin (iSIL)
17 Not yet recruiting Study of MK-5172 and MK-8742 in Japanese Participants With Chronic Hepatitis C (MK-5172-058)
Condition: Hepatitis C
Interventions: Drug: MK-5172;   Drug: MK-8742;   Drug: Placebo
18 Not yet recruiting Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection
Condition: Chronic Hepatitis C
Interventions: Drug: LDV/SOF;   Drug: RBV
19 Recruiting Safety and Efficacy of MK-5172 + MK-8742 in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)
Condition: Hepatitis C Virus
Interventions: Drug: MK-5172;   Drug: MK-8742;   Drug: Placebo to MK-5172;   Drug: Placebo to MK-8742
20 Recruiting Study of MK-5172 + MK-8742 + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048)
Condition: Hepatitis C Virus
Interventions: Drug: MK-5172;   Drug: MK-8742;   Drug: Ribavirin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years